300298 三诺生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.1442.86410.1399.18615.138
总资产报酬率 ROA (%)1.6621.5365.4274.6928.629
投入资产回报率 ROIC (%)2.1862.0166.9965.80510.151

边际利润分析
销售毛利率 (%)52.50948.73854.88053.54452.888
营业利润率 (%)9.4911.3748.9806.7769.506
息税前利润/营业总收入 (%)10.5572.3449.3487.33414.508
净利润/营业总收入 (%)8.3100.4747.7844.82512.415

收益指标分析
经营活动净收益/利润总额(%)104.810270.093101.678132.06471.831
价值变动净收益/利润总额(%)0.5813.709-0.4040.2950.140
营业外收支净额/利润总额(%)2.30013.567-0.940-10.64130.244

偿债能力分析
流动比率 (X)1.1951.1431.4061.5081.448
速动比率 (X)0.8190.7911.0151.0551.043
资产负债率 (%)40.93742.23338.17841.44246.041
带息债务/全部投入资本 (%)26.36527.51924.34729.82534.058
股东权益/带息债务 (%)265.863250.485295.077221.812177.687
股东权益/负债合计 (%)130.782123.622144.236125.339109.149
利息保障倍数 (X)12.5193.10620.6926.06316.488

营运能力分析
应收账款周转天数 (天)38.33543.78844.50146.42635.445
存货周转天数 (天)113.917107.242116.301123.86796.269